Dr. PIYALI MANDAL

 

 

Current designation :

Additional professor ( Since July 2021)

National Drug Dependence Treatment Centre &Department of Psychiatry

All India Institute of Medical Sciences

New Delhi-110029

 

Contact information  :

Contact address 4^th floor academic building

Department of Psychiatry &NDDTC

AIIMS, New Delhi-110029  

Email This email address is being protected from spambots. You need JavaScript enabled to view it.  

Telephone +919899620279, Contact no: 011-26593236

 

 

Work experience  

• Associate Professor: at the NDDTC and department of Psychiatry, AIIMS, New Delhi from July, 2018-June 2021

• Assistant Professor: at the NDDTC and department of Psychiatry, AIIMS, New Delhi from 8^th June, 2015

• Senior Research Associate: at the department of Psychiatry and NDDTC,AIIMS, New Delhi from September, 2014- June, 015

• Senior resident: at the department of Psychiatry and NDDTC,AIIMS, New Delhi from February2012-August 2014

• Senior resident: in the department of Psychiatry, Institute of Human Behaviour and Allied Sciences( IHBAS), Delhi from August 2011- January 2012

• Junior resident( MD): in the department of Psychiatry and NDDTC,AIIMS, New Delhi from 2008-2011

• Junior resident : in the department of Paediatrics ,Institute of child Health, Kolkata, from 2005-2007

 

 

Professional Education  :

 

M.D. ( Doctor of Medicine) in Psychiatry, All India Institute of Medical Sciences, New Delhi

 

D.Ch (Diploma in Child Health) in Paediatrics, Institute of child Health, Kolkata

 

M.B.B.S from Medical College, Kolkata

 

 

Professional Recognition/ Awards

 

S.No	Name of Award	Awarding Agency	Year
1	ICMR financial assistance for MD thesis	ICMR	2009
2	International travel award	National Institute of Drug Abuse	2013
3	Early career investigator poster award	World Congress of Asian Psychiatry	2013
4	Travel award	CSIR	2013
5	Travel award	ICMR	2013
6	Travel award	DST	2014
7	WHO-ISAM Grants-In-Aid-Of-Travel Fellowship	International Society of Addiction Medicine	2014
8	International travel award	National Institute of Drug Abuse	2020

Area of interest: Substance use among women ,Adolescent substance use

 

Funded projects

Principal investigator for the project titled

• “Psycho-social correlates of drug use among attendees of Women’s Clinic of National Drug Dependence treatment Centre” under AIIMS Intramural funding ( 2017-2020)

• “Role of significant others involvement in retention and outcome on naltrexone among opioid dependent individuals: An open label comparative study” under AIIMS Intramural funding ( 2020-2022)

• “Self-esteem, coping and general functioning among women seeking treatment for substance use disorders: A comparative study” under AIIMS Intramural funding ( 2019-2020) as CO-PI

 

 

As co-investigator

• Detection of naltrexone in urine by LC-QTOF-Mass spectrometry and its application to naltrexone compliance in substance users (non-funded)

• Screening and intervention for substance use among middle school going children in Delhi funded by Dept. of Education, Samagra Siksha Abhiyan Government of Delhi & NCT ( completed)

• Screening and intervention for substance use among high school going children in Delhi funded by Dept. of Education, Samagra Siksha Abhiyan , Government of Delhi & NCTA cross sectional study to measure (completed)

• Extent of mental health issues and addictive behaviour among adolescents seeking help in Adolescent Friendly Health Clinics in Delhi” funded by Government of Delhi & NCT (completed)

• Impact of COVID-19 pandemic and related lockdown on pattern of psychoactive substance use, treatment service utilization, psychosocial functioning, and health promoting behavior in treatment seeking alcohol and drug dependent individuals under AIIMS Covid related projects funding ( 2020) (completed)

• Survey on alcohol and drug use among school and college students” funded by Ministry of Social Justice and Empowerment & NDDTC (completed)

• Barriers and facilitators of addiction treatment: A qualitative study funded by ICSSR (completed)

• An efficient screening method for simultaneous detection of Pentazocine, Pheniramine and Tramadol in urine of substance users by gas chromatography-Mass spectrometry (non-funded) ( ongoing)

• COVID-19 experience and literacy among substance use disorder (SUD) patients.(non-funded) (ongoing)

• Development and pilot-testing of training modules on Substance Use for staff working in Integrated Rehabilitation Centre for Addicts (IRCAs) and Child Welfare Police Officers (CWPOs)funded byMoSJE, GOI (ongoing)

 

 

 Journal responsibilities

Peer reviewer for

• Journal of Psychoactive Drugs ( International)

• International Journal of Psychiatry in Medicine ( International)

• Journal of Substance Use (International)

• Indian Journal of Social Psychiatry

• Journal of Mental Health and Human Behaviour

• National Medical Journal

 

 

Publications ( Total -68)

Book chapter

• Ambekar A, Mandal P. Substance related disorders. In: Singh PK, Singh OP, Kumar V. editors. IPS Textbook of Undergraduate Psychiatry.1 st ed. New Delhi: Jaypee brothers medical publishers; p 90-109

• Ambekar A, Mandal P, Prajapati N. Substance abuse in women: An International Perspective In “Handbook on Women Mental Health: An Indian Perspective”. National Publisher. Under Publication

• Mandal P, Verma K, Ambekar A.Management of Substance use disorders .In Treatment Guidelines for Perinatal Psychiatry. Indian Association of Private Psychiatry and Indian Association of Biological Psychiatry. Under Publication

 

 

Full text publications in peer reviewed indexed journals  

1. Sarkar S, Thakur A, Sood A, Mandal P .Barriers and Facilitators of Addiction Treatment: A Qualitative Study.International Journalof Mental Health and Addiction ISSN 1557-1874 Int J Ment Health Addiction DOI 10.1007/s11469-020-00394-x

2. Vishwakarma A, Tarwani J, Chawla N, Dayal P, Agrawal A, Mandal P, Ambekar A. Mephentermine dependence with induced psychosis: a series of two cases, J Subst Use, 2020. DOI: 10.1080/14659891.2020.1749949

3. Chattopadhyay A,Gupta S, Dayal P, Mandal P, Agrawal A, Ambekar A. Butorphanol dependence in a health-care professional: A case report with narrative review. J Subst Use 2019; 24(5):463-4. Doi:10.1080/14659891.2019.1604839

4. Mandal P, Parmar A, Ambekar A, Dhawan A. Substance use among treatment seeking Indian adolescent girls: Are they unique? Asian J Psychiatr. 2019;41:17-9. doi: 10.1016/j.ajp.2019.03.007. Epub 2019 Mar 6.

5. Chawla N, Mandal P, Chatterjee B, Dhawan A. Tramadol associated pica: A case report. Psychiatry clinNeurosci. 2019 ;73(1):43. doi: 10.1111/pcn.12789. Epub 2018 Dec 2.

6. Mandal P, Dhawan A. Interventions in individuals with specific needs. Indian J Psychiatry2018,60(8): 553-58

7. Dhawan A, Mandal P. Preventive strategies for substance use. Indian J Soc Psychiatry2017,33(2):108-11

8. Ambekar A, Parmar P. Tirthani S, Mandal P. Profile of women substance users seeking treatment at tertiary care treatment centre: A retrospective chart review study. J Subst Use 2017, 22( 5): 507-10.doi.10.1080/14659891.2016.1255792

9. Mandal P, Parmar P. Tirthani S, Ambekar A. Profile of elderly women seeking treatment for substance use disorders at a tertiary care treatment centre. J Subst Use 2017,22(3):353-55.doi.org/10.1080/14659891.2016.1217092

10. Parmar A, Mandal P, Tripathi M, Sagar R Escitalopram Induced Hyponatremia. ASEAN J Psychiatry 2016, 17 (2): 254-57

11. Gupta P,  Mandal P,  Singh D,   Pattanayak RD,  Bhargava R, Anju Dhawan A. Detection of Optic Neuropathy and 3-month Follow-up of an Adolescent Inhalant User: Are we Paying Enough Attention? Indian J Psychol Med. 2016; 38(5): 486–88.doi:  10.4103/0253-7176.191390

12. Rao R, Mandal P , Gupta R, Ramshankar P , Mishra A , Ambekar A , Jhanjee S, Dhawan A. Factors Affecting Drug Use During Incarceration: A Cross-Sectional Study of Opioid-Dependent Persons from India. J Subst Abuse Treat. 2016;(61):13–7Mandal P,Prakash S."Tramadol: a good option for management of opioid withdrawal syndrome in developing countries." J Subst Use, 2016,21(4) : 339–40

13. Pal A, Parmar A, Mandal P, Sagar R. A case of persistent delusional disorder: Role of dimensions of delusion reappraised. J Mental Health Human Behav. 2016; 21(1): 64-5

14. Mandal P, Jain R, Jhanjee S, Sreenivas V. Psychological Barriers to Tobacco Cessation in Indian Buprenorphine-Naloxone Maintained Patients: A Pilot Study. Indian J Psychol Med. 2015 Jul-Sep; 37(3): 299–304. doi:  10.4103/0253-7176.162944

15. Prakash S, Mandal P. Is dhat syndrome indeed a culturally determined form of depression? Ind J Psychol Med 2015; 37(1):108-9

16. Prakash S, Mandal P. Drug trials in psychiatry: Methodological issues. Asian J Psychiatry. 2014; 8:109-10.

17. Prakash S, Mandal P. Is the DSM-5 position on dhat syndrome justified?Asian J Psychiatry. 2014; 12:155-57.DOI: http://dx.doi.org/10.1016/j.ajp.2014.08.006

18. Prakash S, Mandal P. Psychiatry’s dilemma: A poorly valid symptom based classification versus a yet infantile neuroscience based classification. Asian J Psychiatry. 2014;13:83-4

19. Prakash S, Mandal P. Dhat syndrome: An extremely unusual presentation. World Cul Psych Res Rev World Cultural Psychiatry Research Review 2014; 9 (3): 140-3

20. Prakash S, Mandal P.Medically Unexplained Somatic Symptoms – Diagnostic and Treatment Issues in the Indian Subcontinent. Am J Psychiatry.2014; 171(11):1158-9.

21. Gupta A, Mandal P, Rachna Bhargava R, Pattanayak RD, Sagar R, Dhawan A.Marked Exacerbation of ADHD After Onset of Inhalant Use: A Case Report. J Neuropsychiatry Clin Neurosci. 2014 26(4): E6-E7

22. Mandal P, Prakash S, Sagar R. Primary caregivers of schizophrenia outpatients: burden and its correlates. Delhi Psychiatry J. 2014; 17(2):343-8.

23. Prakash S, Mandal P.Is the DSM-5 position on dhat syndrome justified? Asian J psychiatry. 2014, 27(12):155-7.

24. Mandal P, Prakash S. Stigma of mental disorders and role of nursing professionals: A developing country perspective. J nursing & care. 2014; 3(5):190. http://dx.doi.org/10.4172/2167-1168.1000190

25. Mandal P, Prakash S. Methodological considerations in studying psycho-social aspects of suicide. Ind J psychiatry. 2014; 56 (2):208-9.

26. Prakash S, Mandal P. Improving somatic health in severe mental illness. Acta Psychiatr Scand. 2014; 129(3):236-7.

27. Prakash S, Mandal P. Natural Disasters, Armed Conflict, and Public Health. N Eng J Med. 2014; 370(8):783.

28. Srivastava P, Mandal P, Mehta M, Sagar R. Psychological Intervention in a Case of Bulimia Nervosa: A Case Report. Psychol Studies. 2014; 59(1):68–75.

29. Prakash S, Mandal P. Culture bound syndromes: Nosological and management issues. Ind J Psychiatry 2014; 56(1):99.

30. Mandal P, S. Arumuganathan, Rajesh Sagar, Pakhi Srivastava. A Classical Case of Bulimia Nervosa from India. Indian J Psychol Med .2013; 35 (3): 309-10.

31. Mandal P, Prakash S, Deb KS. Schizophrenia caregivers’ burden: Need to look deeper. Asian J Psychiatry. 2013 Oct; 6(5):428.

32. Mandal P, Pal A, Sagar R. Common mental disorders-A review. J Mental Health Human Behav 2013,8(2):6-14

33. Prakash S, Mandal P, Sagar R. Paroxetine in the treatment of recurrent brief depressive disorder. J Pharmacol Pharmacother. 2013; 4(4): 288–290.

34. Thapa R, Mallick D, Mandal P, Ghosh A. Neuroblastoma masquerading as juvenile idiopathic arthritis. Indian J Pediatrics. 2007; 74(4): 421-422

 

 

Abstract published in indexed journals

 

1. Verma K, Mandal P, Mongia M, Ambekar A. Perceived stigma and Affiliate stigma among family members of opioid dependent men and women: A cross sectional comparative study. Indian J Psychiatry 2020; 62(S1): S31

2. Jhanjee S, Mandal P, Chatterjee B. Tobacco use in vulnerable populations in India: A review. Indian J Psychiatry 2020; 62(S1): S93

3. Chatterjee B , Mandal P , Rao R , Kattula D. Rehabilitation of special populations in addiction psychiatry. Indian J Soc Psychiatry 2019; 35(4): 275

4. Verma K, Mandal P, Mongia M, Ambekar A. Perceived stigma in female opioid users and their family members: A cross sectional comparative study. Indian J Soc Psychiatry 2019; 35(4): 287

5. Ambekar A, Mandal P , Pakhre A , Tripathi R. Substance Use Disorders in Women – Assessment and Management Issues. Indian J Psychiatry. 2019; 61 (S- 3): 435

6. Parmar A, Mandal P, Ambekar A, Dhawan A. Substance use among female adolescents seeking treatment: A study from a tertiary care substance use treatment centre. Indian J Soc Psychiatry. 2018;34(4): 352

7. Jhanjee S, Jain R, Mandal P. E-cigarettes in adolescents: Issues and challenges. Indian J Psychiatry. 2018; 60:S-43

8. Mandal P, Varshney M, Das N, Dhawan A. Profile of adolescent opioid users seeking treatment at a national level addiction treatment centre. Indian J Psychiatry. 2018; 60: S-151

9. Mandal P, Kuppili PP, Bhargava R, Pattanayak RD, Dhawan A. Clinical profile and retention on pharmacological treatment among opioid dependent adolescents: A retrospective chart review. The Indian J Ped. 2017;SS-1:118

10. Sharma S, Mandal P, Mongia M, Ambekar A. Barriers to Treatment and Psychosocial Complications of Prescription Opioid Dependence in Women in Indian Context: A Case Report and Brief Review. Indian J Soc Psychiatry 2017, 33: S-14

11. Kamran A, Garg H, Varshney M, Agrawal A, Dayal P, Mandal P, Ambekar A. Iatrogenic Opioid Use Disorder In A Young Woman: A Case Report With Unique Clinical Characteristics. Indian J Psychiatry. 2017; 59(S2): 239

12. Shah B, Yadav P, Ambekar A, Mandal P. Gender Sensitive Substance Use Treatment Services: Challenges and Opportunities. Indian J Psychiatry 2016;58(S1): S41

13. Bhargava R, Mandal P, Gupta A, Dhawan A. Psychosocial Determinants of Drop-Out From Treatment At Child & Adolescent Clinic of National Drug Dependence Treatment Centre. Indian J Psychiatry 2016;58(S1): S-121

14. Jhanjee S, Jain R, Chatterjee B, Mandal P. E-Cigarettes Use: Is it an Acceptable Alternative? Indian J Soc Psychiatry 2016.32(4): 386 

15. Mandal P, Chatterjee B, Sagar R, Prakash S. Stigma Towards Mentally Ill Among Health Care Staffs in India and Way Forward. Indian J Soc Psychiatry 2016.32(4):413

16. Parmar A, Mandal P, Therthani S, Ambekar A. A Retrospective Chart Review of Female Substance Users Attending Outpatient Clinic at Tertiary Care Drug Dependence Treatment Centre in India. Indian J Soc Psychiatry 2016.32(4):455

17. Kuppili PP, Bhargava R, Mandal P, Mishra AK, Gupta A, Dhawan A. Correlates of treatment retention among children & adolescent substance users seeking treatment in tertiary hospital in North India. Indian J Soc Psychiatry 2016.32(4):459

18. Chatterjee B, Mandal P, Sagar R, Kumar N. Attitude towards mentally ill among nursing Professionals: Evidence from a Tertiary Care General Hospital. Indian J Psychiatry 2015;57(S): 92

19. Krishnan V, Ambekar A, Mandal P, Rao R, Mishra AK. Outcomes on buprenorphine-naloxone at a tertiary care substance use facility: a retrospective chart review. Indian J Psychiatry 2015;57(S):102

20. Jhanjee S, Mandal P, Singh D. Tobacco use in opioid-dependent patients on buprenorphine-naloxone treatment. Ind J Psychiatry Jan 2014; 56 (Suppl 1): S19–S20

21. Mandal P, Jain R, Jhanjee S, Sreenivas V. Barriers of tobacco cessation among Indian buprenorphine-naloxone maintained patients. Alcohol alcohol. 2014; 49(suppl1): i6.doi: 10.1093/alcalc/agu052.19

22. Chatterjee B, Sagar R, Mandal P, Kumar N. Mental illness: Who do the professional blame? Ind J Psychiatry Jan 2013; 55(S 1): S61–S62

 

 

Abstracts published in conference abstract book/ International abstract data base

 

23. Mandal P, Dhawan A. Indian adolescent opioid users and their clinical profile and management challenges: A retrospective analysis of 5 years. In abstract database Joint NIDA (USA) & CPDD virtual meeting database 2020, June19-24, online

24. Mandal P. E-cigarette use: what is the raging debate? In: The proceedings of World congress of Mental Health.2017 November 2-5;New Delhi, India.

25. Mandal P. Women and drug use: addressing the treatment needs. In: Abstracts of First national conference on Addiction Psychiatry; 2017 November 27-29;New Delhi, India.

26. Chawla N, Mandal P, Chatterjee B, Dhawan A.  Tramadol induced pica. In: Abstracts of First national conference on Addiction Psychiatry; 2017 November 27-29;New Delhi, India

27. Mandal P. The role of the glutamate and cannabinoid neurotransmitter systems in the nicotine dependence and their treatment implications. In abstracts of 34^th Annual meeting of Indian Academy of Neurosciences; 2016 October 19-21; National Brain Research Centre, Manesar, India

28. Mandal P, Dhawan A, Bhargava R, Sharma S. A retrospective study of factors associated with management of adolescent substance use. In: the proceedings of the 7th Congress of the Asian Society for Child and Adolescent Psychiatry and Allied Professions (ASCAPAP) 2013 September 14-18, New Delhi, India

29. Mandal P, Chatterjee B, , Rakesh VR, Kumar N, Sagar R. Community Attitude towards Mentally and Their Treatment among Nursing Professionals in a Tertiary Care General Hospital. In: Abstracts of the 4^th World Congress of Asian Psychiatry; 2013 August 20-23; Bangkok, Thailand

30. Mandal P, Jain R, Jhanjee S, Sreenivas V. Tobacco use in opioid-dependent subjects on buprenorphine-naloxone maintenance treatment. In: Abstract database of NIDA International forum 2013. June 14 -17;San Diego, USA

 

Invited Lectures/ CME/ academic presentations

• Invited lectures:

  • Delivered symposium titled “Tobacco use: Across life span of women” in ADDICON 2021, Virtual, 10-11^th December,2021, India

  • Delivered symposium titled “School setting and intervention: Background and review”. Presented at WASP Asia-Pacific Hybrid congress, 16-18^th September,2021, New Delhi, India

  • Delivered symposium titled “Genes and gender differences in substance use”. Presented at Hybrid

  • Delivered symposium titled “Interventions for substance use in school setting”. Presented at Hybrid NCIASP , 26-28^th November, 2021, Imphal, Manipur, India

  • Delivered invited lecture titled “Management of Opioid Dependence -withdrawal management” online for Online Orientation Programme for Resource persons (Psychiatrists) on Management of SUD organized by NDDTC funded by The Drug De-Addiction Programme, Ministry of Health and Family Welfareon 1-6^th March, 2021

  • Delivered invited lecture titled “Management of Opioid Dependence -withdrawal management” online for Online Orientation Programme for Resource persons (Psychiatrists) on Management of SUD organized by NDDTC funded by The Drug De-Addiction Programme, Ministry of Health and Family Welfareon 19-24^th October, 2020

  • Invited as an expert for capacity building of the staffs of Women Deaddiction Centre at Pardabagh, Daryaganj, Delhi run by NGO, Society for Youth and Masses (SPYM)

  • Delivered symposium titled “Women and tobacco use” in 72nd Annual National Conference of Indian Psychiatric Society held on January 22-25,2020 Kolkata

• Delivered symposium titled “Rehabilitation in women” in National Conference of the Indian Association for Social Psychiatry (NCIASP) held on 29 November – 01 December, 2019Bhubaneswar

• Delivered invited lecture titled “ Opioid Dependence Syndrome” in the Nurses training of trainers program on substance use disorders, AIIMS Delhi College of Nursing on 30th November,2019

• Delivered symposium titled “Addressing the need: More women psychiatrists to fill the gap” in XXI International Society of Addiction Medicine Meeting November 13-16,2019 New Delhi

• Delivered symposium titled “Intervention for substance use among adolescents across settings: scope and relevance: Interventions in the community” XXI International Society of Addiction Medicine Meeting November 13-16,2019 New Delhi

• Delivered invited lecture titled “Overview of substance use disorders and relevance to the police force” for battalion 49B, PAC on 12 April, 2019 at Gautam Buddh Nagar , UP

• Delivered symposium titled “ Substance Use Disorders in Women – Assessment and Management Issues ” in 71st Annual National Conference of Indian Psychiatric Society held on January 31-3^rd February, 2019,Lucknow

• Delivered invited lecture titled “Women in addiction; issues, concerns and service gaps” in the 7th National FINGODAP conference organized by SPYM and National Institute of Social Defence on 30^thMarch, 2019 at Dr Ambedkar International Centre, New Delhi

• Invited as an expert in the Regional workshop on piloting UNODC Family Treatment Package for youths with drug use disorder” (UNFT) to finalize the cultural adaptations needed in the treatment package (December 2018)in Colombo, Srilanka

• Delivered symposium titled “Women & drug use: Addressing the treatment needs” in the 1^st National conference on Addiction Psychiatry; organized by Dept. of Psychiatry, AIIMS, 27-29 November,2017 New Delhi, India

• Delivered invited lecture titled “ Gender sensitive interventions: An overview” in the National CMEon “Emerging Issues in Substance Use Disorders", New Delhi, 22^nd July 2017

• Delivered symposium titled “Do e-cigarettes help to quit tobacco use- what is the evidence? In symposium entitled “E- Cigarettes Use: Is it an acceptable alternative?” 22nd World Congress of Social Psychiatry (WASP). 30^th November,2016, New Delhi , India

• Delivered symposium titled “The role of the glutamate and cannabinoid neurotransmitter systems in nicotine dependence and their treatment implications”. 34^th Annual Meeting of Indian Academy of Neurosciences. 19^th October, 2016. National Brain Research Centre, Manesar, India

 

Conference/ CME Organization

• Organizing secretary: For 18^th Annual Day of NDDTC held on 13^th April, 2021

• Organized symposium on “COVID-19 Pandemic and Drug Addiction Treatment” on 18^th annual day NDDTC on 13^th April, 2021

• Organized “ Emergency management Orientation and training of residents and nursing officers on emergency management on 29th January,2021 at NDDTC

• Organizingcommitteemembero21stAnnualmeetingoftheInternationalSocietyof Addiction Medicine in Delhi on13-16th November,2019

• National CME on CL Psychiatry organized by the department of Psychiatry& NDDTC on 9^th April,2018

• 1^st National Conclave on “Psychological Trauma, Child Protection & Mental Illness” organized by Dept. of Psychiatry, AIIMS, 27-28 March 2018, New Delhi, India

• 1^st National conference on Addiction Psychiatry; organized by Dept. of Psychiatry, AIIMS, 27-29 November,2017 New Delhi, India

• Organizing secretary: For 14^th Annual Day of NDDTC held on 13^th April, 2017

• Organized symposium on “Women and drug use” on 14^th annual day NDDTC on 13^th April,2017 . The title of my presentation was “Addiction treatment services for women: a need of the hour”

• “XXII World Congress of the World Association for Social Psychiatry”, from 2016 November 30^th - December 4^th, New Delhi, India

• National symposium of Preventive Psychiatry”; organized by Dept. of Psychiatry, AIIMS, on 2016 September 11^th, Delhi, India

• Annual CME on Substance Use Disorders titled “Alcohol Use Disorders: Contemporary Issues” organized by National Drug Dependence Treatment Centre, AIIMS on 2016 April 30^th, Delhi, India

 

 

Conference attended

International

 

1. WASP Asia-Pacific Hybrid Congress,2021 September 16-18, New Delhi

2. NIDA( USA ) and CPDD Joint virtual Meeting, 2020 June 19-24, Online

3. 21^st International Society of Addiction Medicine Annual Meeting, 2019 November 13-16, New Delhi, India

4. 22^nd World Congress of Social Psychiatry, 2016 November 30-December 4, New Delhi, India

5. The 16^th International Society of Addiction Medicine Annual Meeting, 2014 October 2-6, Yokohama, Japan

6. 7th Congress of the Asian Society for Child and Adolescent Psychiatry and Allied Professions (ASCAPAP) 2013 September 25-28, New Delhi, India

7. NIDA International forum; 2013 June 14 -17;San Diego, CA, USA

8. 4^th World Congress of Asian Psychiatry; 2013 August 20-23; Bangkok, Thailand

 

 

National

1. ADDICON,2021 December 10-11, Virtual

2. 72^nd Annual National Conference of Indian Psychiatric Society. 2020 January22-25, Kolkata, India

3. 71^st Annual National Conference of Indian Psychiatric Society. 2019 January 31-February 3, Lucknow, India

4. First National conclave on Psychological trauma, Child protection and Mental Health, 2018 March 27-28; New Delhi, India.

5. First national conference on Addiction Psychiatry, 2017 November 27-29;New Delhi, India

6. 11^th World Congress on Adolescent Health, 2017 October 27-29;New Delhi, India

7. Annual National conference on Addiction Psychology. 2017 September 7-8, Ghaziabad, India

8. 34^th Annual meeting of Indian Academy of Neurosciences; 2016 October 19-21; National Brain Research Centre, Manesar, India

9. 12th Biennial Conference of the Indian Association for Child and Adolescent Mental Health, 2013 September 25-28, New Delhi, India

10. 65^th Annual National Conference of Indian Psychiatric Society. 2013 January 10-13, NIMHANS, Bangalore, India

11. 64^th Annual National Conference of Indian Psychiatric Society. 2012 January 19-22, Kochi, India

12. 3^rd Annual National Conference of Indian Psychiatric Society. 2011 January 16-18, New Delhi, India

13. 62^nd Annual National Conference of Indian Psychiatric Society. 2010 January 17-20, Jaipur, India

 

Membership of professional bodies

• Life Fellow of Addiction Psychiatry Society of India

• Life fellow of the Indian psychiatric Society

• Life fellow of the Indian Association for Social psychiatry

• Life membership of the Society for Promotion of Research & Education in Mental Health & Substance Use (SPREMH)

• Selected member of Autism Certification Board of department of Psychiatry & NDDTC, AIIMS